The US economy remains on track to end the year with a moderate increase in output, according to the median Q4 GDP estimate ...

I reiterate a “Buy” rating on Agilent Technologies, Inc. with a one-year target price of $150 per share, driven by strategic ...

Bank OZK's preferred stock offers a 6.8% yield and is supported by a rock-solid business model and exemplary management, ...

FlexShopper is undergoing a capital structure transformation, aiming to repurchase preferred stock at a discount through a ...

Direct Line's recent operating performance has improved, showing progress in its turnaround program, despite past weak trends ...

Learn about Lifeway Foods' recent stock increase and their openness to a potential sale after rejecting an offer from Danone.

Elastic’s growth in AI boosts its position in the market. Read why ESTC stock's midterm potential is strong, but timing is ...

Adaptive Biotechnologies posted strong Q3 results, beating expectations and reducing losses, while management has done a good ...

Argan's earnings power is set to grow at a rapid pace as a result of AI data centers driving increased demand for power. Find ...

Axsome Therapeutics (NASDAQ:AXSM) said a long-term Phase 3 study of its drug AXS-12 for the treatment of narcolepsy with cataplexy has met its primary endpoint. The study showed AXS-12 was able to ...

Virco Manufacturing Corporation has delivered nearly 40% returns this year, outperforming micro-caps and industrial stocks ...

Apple (NASDAQ:AAPL) is facing challenges to launch its AI model Apple Intelligence for iPhones and other products in China, as a top Chinese official noted that foreign companies would see a long ...